✦ LIBER ✦

Switching from tamoxifen (TAM) to aromatase inhibitors (Als) in the adjuvant treatment of breast cancer (BC) patients (pts). Results from the NORA study

✍ Scribed by M.E. Cazzaniga; Mustacchi; P. Pronzato; A. De Matteis; F. Di Costanzo; E. Rulli; C. Pollera; E. Procaccini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone adjuvant strategies in breast ca

✍ M Cazzaniga; P Pronzato; G Mustacchi; F Di Costanzo; I Floriani; A De Matteis 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 358 KB

356 POSTER Different CMF regimens as adj

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Chemotherapy (CHT) adjuvant strategies a

✍ G Mustacchi; M Cazzaniga; P Pronzato; F Di Costanzo; I Floriani; A De Matteis 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Stick or switch? Audit of the use of swi

✍ S Weeraman, C Hunsley, M Wall, R Kirby 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 390 KB

P68 ECOG stage influences the choice of

✍ M.E. Cazzaniga; G. Mustacchi; A. De Matteis; F. Di Costanzo; P. Pronzato; G. Ber 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Pilot study of acupuncture for the treat

✍ Katherine D. Crew; Jillian L. Capodice; Heather Greenlee; Arlyn Apollo; Judith S 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 201 KB